Global Warfarin Market Is Expected To Grow At A CAGR of 2.3% from 2020 to 2027
Warfarin is classified as an anticoagulant which is used to prevent the formation of blood clot and migraine. It is a vitamin K antagonist that inhibits its production by the vitamin K epoxide reductase. Atrial fibrillation is representing the largest market share in the clinical application segment for the warfarin market. As per the latest information provided by the National Institute of Health (NIH), the global prevalence rate of atrial fibrillation has increased by 33% over the last 2 years. DVT/PE will be highlighting comfortable market growth in the near…
Read More